Brief: Zydus Lifesciences Receives EIR For Oncology Injectable Manufacturing Facility In SEZ1, Ahmedabad
April 16 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS: ZYDUS LIFESCIENCES- ZYDUS RECEIVES EIR FOR ONCOLOGY INJECTABLE MANUFACTURING FACILITY IN SEZ1, AHMEDABAD Source text: ID:nnAZN4SR4T1 Further company coverage: ZYDU.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka